Systemic therapy for metastatic colorect
β
Dan S. Zuckerman; Jeffrey W. Clark
π
Article
π
2008
π
John Wiley and Sons
π
English
β 204 KB
## Abstract A proliferation of new cytotoxic and biologic agents has led to improved survival in patients with metastatic colorectal cancer (mCRC). The ability of surgery to increase longβterm survival in patients with liver and/or lung metastases also has been firmly established. It has become inc